NeuroOne Medical Technologies Corp當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名89/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為強力買入。最高目標價2.23。中期看,股價處於下降通道。近一個月,市場表現很強,技術面和基本面綜合得分較高,很強的走勢得到基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。
NeuroOne Medical Technologies Corp評分
相關信息
行業排名
89 / 208
全市場排名
214 / 4582
所屬行業
醫療設備與耗材
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
2
分析師
強力買入
評級
2.225
目標均價
+239.69%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
NeuroOne Medical Technologies Corp亮點
亮點風險
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
公司代碼NMTC
公司NeuroOne Medical Technologies Corp
CEORosa (David A)
網址https://nmtc1.com/
常見問題
NeuroOne Medical Technologies Corp(NMTC)的當前股價是多少?
NeuroOne Medical Technologies Corp(NMTC)的當前股價是 0.734。
NeuroOne Medical Technologies Corp 的股票代碼是什麼?
NeuroOne Medical Technologies Corp的股票代碼是NMTC。
NeuroOne Medical Technologies Corp股票的52週最高點是多少?
NeuroOne Medical Technologies Corp股票的52週最高點是1.390。
NeuroOne Medical Technologies Corp股票的52週最低點是多少?
NeuroOne Medical Technologies Corp股票的52週最低點是0.395。
NeuroOne Medical Technologies Corp的市值是多少?
NeuroOne Medical Technologies Corp的市值是36.58M。
NeuroOne Medical Technologies Corp的淨利潤是多少?
NeuroOne Medical Technologies Corp的淨利潤為-12.32M。
現在NeuroOne Medical Technologies Corp(NMTC)的股票是買入、持有還是賣出?
根據分析師評級,NeuroOne Medical Technologies Corp(NMTC)的總體評級為--,目標價格為2.225。
NeuroOne Medical Technologies Corp(NMTC)股票的每股收益(EPS TTM)是多少
NeuroOne Medical Technologies Corp(NMTC)股票的每股收益(EPS TTM)是-0.166。